Global Companion Diagnostics market | Inkwood Research

1
GLOBAL COMPANION DIAGNOSTICS MARKET

• FORECAST 2018-2026

1
2
MARKET OVERVIEW
GLOBAL COMPANION DIAGNOSTICS MARKET FORECAST
2018-2026

• The global companion diagnostics market is
  segmented on the basis of technology, products
  and services, indications and end-users.
• The technology segment includes polymerase chain
  reaction, in situ hybridization,
  immunohistochemistry, next-generation sequencing
  and other technologies.
• The product and service segment includes assay
  kits and reagents and software and service.
• The indication segment is further classified into
  oncology, neurology, infectious diseases and
  other indications.
• The market caters to end-users like
  pharmaceutical and biopharmaceutical companies,
  reference laboratories and other end users.

3
INTRODUCTION
KEY FINDINGS

• The global companion diagnostics market is driven
  by factors such as the widespread of cancer
  disease across the globe, high demand for target
  therapies and strategic initiatives for companion
  diagnostics test development.
• By the end of the forecast period of 2018-2026,
  the market is expected to rise with a 18.45 CAGR.

• Global Companion Diagnostics market by Products
  and Services, by Indication, by End user, by
  Technology by geography.

4
Infographic
5
REQUEST FREE SAMPLE
To know more about the latest trends and
innovation in the Global Companion Diagnostics
market
Request free sample
5
6
NORTH AMERICA COMPANION DIAGNOSTICS MARKET

• The North America companion diagnostics market is
  projected to rise with a CAGR of 18.62 over the
  forecast period of 2018-2026.
• Initiatives to promote precision medicine
  research along with the strategic alliances
  between key market players for companion
  diagnostics test development are factors that are
  responsible for propelling the market growth.

Request free sample
6
7
EUROPE COMPANION DIAGNOSTICS MARKET

• High demand for target therapy and growing
  efforts to develop advanced companion diagnostics
  tests are factors that are driving growth in the
  Europe companion diagnostics market.
• Over the forecast period of 2018-2026, the Europe
  companion diagnostic market is expected to
  register a CAGR of 18.17.

Request free sample
7
8
ASIA PACIFIC COMPANION DIAGNOSTICS MARKET

• The Asia-Pacific companion diagnostics market is
  predicted to show the highest CAGR of 18.79 over
  the forecast period of 2018-2026.
• China, India and Japan are the major contributors
  to this market.

Request free sample
8
9
COMPETITIVE INSIGHTS

• Leading players in the global companion
  diagnostics market are Abbott Laboratories, Almac
  Group, Arup Laboratories, Biocartis, Biomerieux
  S.A, Danaher Corporation, Ge Healthcare, Genomic
  Health, Illumina Inc, Myriad Genetics Inc, Qiagen
  N.V, Roche Diagnostics (A Hoffmann-La Roche Ag
  Divison), Sysmex Corporation, and Thermo Fisher
  Scientific Inc.

9
10
(No Transcript)
11
CONTACT US

• 1 857-302-4704

• sales_at_inkwoodresearch.com

• https//www.inkwoodresearch.com/

10
12

• THANK YOU

Follow us on
12